Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications
Naoyoshi Nagata, Tadashi Takeuchi, Hiroaki Masuoka, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 272-288
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 70
Reinforcement of the intestinal mucosal barrier via mucus-penetrating PEGylated bacteria
Yanmei Chen, Sisi Lin, Lu Wang, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 7, pp. 823-841
Closed Access | Times Cited: 31
The gut–airway microbiome axis in health and respiratory diseases
Mustafa Özçam, Susan V. Lynch
Nature Reviews Microbiology (2024) Vol. 22, Iss. 8, pp. 492-506
Closed Access | Times Cited: 27
Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair
Veronica Marrella, Federico Nicchiotti, Barbara Cassani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4051-4051
Open Access | Times Cited: 19
The Impact of Food Additives on the Abundance and Composition of Gut Microbiota
Xuewei Zhou, Kaina Qiao, Huimin Wu, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 631-631
Open Access | Times Cited: 34
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Human microbiomes in cancer development and therapy
Chenglai Xia, Jiyan Su, Can Liu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 27
Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin α2β1
Kan Huang, Zilun Li, Xi He, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 598-616.e9
Closed Access | Times Cited: 14
Cancer immunometabolism: advent, challenges, and perspective
Qin Dang, Borui Li, Bing Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment
Mengdi Sun, Fang Lü, Donghua Yu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19
Morgan Essex, Belén Millet Pascual-Leone, Ulrike Löber, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 22
Microbiome-targeted interventions for the control of oral–gut dysbiosis and chronic systemic inflammation
Juan Pacheco‐Yanes, Eric C. Reynolds, Jian Li, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 11, pp. 912-925
Closed Access | Times Cited: 20
Gut microbiota in COVID-19: new insights from inside
Bingqian Zhou, Xiaoqi Pang, Jingyi Wu, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions
Yong Qiu, Chunheng Mo, Lu Chen, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 7
Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches
Tudorița Gabriela Părângă, Ivona Mitu, Mariana Pavel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11411-11411
Open Access | Times Cited: 6
Baseline Gut Microbiome Signatures Correlate with Immunogenicity of SARS-CoV-2 mRNA Vaccines
Lauren Daddi, Yair Dorsett, Tingting Geng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11703-11703
Open Access | Times Cited: 15
Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19
Gerard Baiges‐Gayà, Simona Iftimie, Helena Castañé, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 163-163
Open Access | Times Cited: 13
Cholecystectomy Significantly Alters Gut Microbiota Homeostasis and Metabolic Profiles: A Cross-Sectional Study
Fusheng Xu, Ruimin Chen, Chengcheng Zhang, et al.
Nutrients (2023) Vol. 15, Iss. 20, pp. 4399-4399
Open Access | Times Cited: 13
What Makes the Gut-Lung Axis Working? From the Perspective of Microbiota and Traditional Chinese Medicine
Hui Wang, Ying Wang
Canadian Journal of Infectious Diseases and Medical Microbiology (2024) Vol. 2024, pp. 1-15
Open Access | Times Cited: 5
Metabolic Homeostasis of Amino Acids and Diabetic Kidney Disease
Liu Luo-kun, Jingge Xu, Zhiyu Zhang, et al.
Nutrients (2022) Vol. 15, Iss. 1, pp. 184-184
Open Access | Times Cited: 22
The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature
Kimia Vakili, Mobina Fathi, Shirin Yaghoobpoor, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
Association between microbiota and immune response to Sars-CoV-2 infection
Antonio Vitiello, Andrea Zovi, Francesco Ferrara
Infectious Diseases Now (2023) Vol. 53, Iss. 4, pp. 104646-104646
Open Access | Times Cited: 11
Exploring gut–lung axis crosstalk in SARS‐CoV‐2 infection: Insights from a hACE2 mouse model
Yu Zhang, Ma Yifang, Weiyang Sun, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 4
Bibliometric Analysis of the Relationship between Gut Microbiota and Chronic Kidney Disease from 2001–2022
Pengyu Tao, Jinlin Huo, Ling Chen
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 1
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top